Viridian Therapeutics, Inc.\DE (VRDN) Interest Coverage Ratio (2016 - 2025)
Historic Interest Coverage Ratio for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to 71.45.
- Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio rose 5472.21% to 71.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 108.43, marking a year-over-year decrease of 71.65%. This contributed to the annual value of 98.17 for FY2024, which is 2873.82% up from last year.
- As of Q3 2025, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio stood at 71.45, which was up 5472.21% from 207.72 recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio ranged from a high of 64.04 in Q4 2024 and a low of 9693.67 during Q4 2021
- In the last 5 years, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio had a median value of 160.18 in 2025 and averaged 813.09.
- As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio crashed by 182593.66% in 2021, and later surged by 9698.71% in 2022.
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio (Quarter) stood at 9693.67 in 2021, then surged by 96.99% to 292.06 in 2022, then skyrocketed by 73.28% to 78.03 in 2023, then rose by 17.94% to 64.04 in 2024, then fell by 11.58% to 71.45 in 2025.
- Its last three reported values are 71.45 in Q3 2025, 207.72 for Q2 2025, and 160.18 during Q1 2025.